ArticleJournal of cachexia, sarcopenia and muscle2021

The regulatory approval of anamorelin for treatment of cachexia in patients with non-small cell lung cancer, gastric cancer, pancreatic cancer, and colorectal cancer in Japan: facts and numbers.

Hidetaka Wakabayashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.